Physician

Keith Iverson Harrop, M.D.

According to 2025 Medicare claims, Keith Harrop, M.D. (NPI: 1093080418) practices internal medicine in the Lynchburg, VA market, with the plurality of this provider's patient population coming from Lynchburg City, VA. This provider's primary affiliated billing organization is M MEDICAL GROUP, INC. (NPI: 1780056168; TIN: 134364280) and primary practice location at 24501-2119. Harrop is affiliated with the LTC ACO (ACO ID: A2973) and Sound Physicians Long Term Care Managment II (ACO ID: A5538), participating under the MSSP model.

Harrop's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 994 traditional Medicare patients, billed 2,493 HCPCS/CPT codes, and received $224,910 in Medicare payments. The top billing code was 99306 (Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more). Part D data shows 32,523 prescription claims across 1,051 beneficiaries totaling $3,040,503 in drug costs, led by Eliquis (Apixaban). DME data shows 979 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $35,444 to $224,910. Similarly, Part D prescription costs have risen steadily, from $4,394 to $3,040,503. For DME billing, reported payments moved sharply higher in recent years, from $2,308 to $93,850.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	152	436	$35,444
2016	474	1,270	$109,351
2017	501	1,304	$114,884
2018	487	1,303	$113,646
2019	334	950	$72,827
2020	732	2,235	$183,001
2021	1,717	2,925	$277,551
2022	1,416	2,307	$209,177
2023	897	1,728	$171,268
2024	994	2,493	$224,910

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	41	146	$4,394
2016	98	378	$37,145
2017	104	365	$37,303
2018	131	428	$25,473
2019	150	517	$35,866
2020	301	3,944	$221,190
2021	546	7,384	$450,994
2022	904	19,066	$1,275,107
2023	936	20,639	$1,889,384
2024	1,051	32,523	$3,040,503

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	40	$1,396
2018	N/R	44	$1,442
2019	N/R	38	$1,528
2020	N/R	80	$8,487
2021	N/R	85	$7,979
2022	208	648	$39,044
2023	500	1,404	$179,251
2024	381	979	$81,112

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99306	Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more	543	665	$134
99310	Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes	132	184	$118
99309	Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes	626	1,353	$77
99497	Advance care planning, first 30 minutes	62	69	$58
G0317	Prolonged nursing facility evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualifi	171	212	$23

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	1,317	19,003	$400,658
Trulicity	Dulaglutide	571	10,344	$379,100
Ingrezza	Valbenazine Tosylate	63	838	$225,513
Austedo	Deutetrabenazine	37	513	$121,074
Xarelto	Rivaroxaban	358	5,058	$102,425

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A6196	Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing	N	24	60	$19,375
A6010	Collagen based wound filler, dry form, sterile, per gram of collagen	N	16	19	$19,208
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	21	82	$5,933
A6212	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing	N	22	41	$5,381
K0003	Lightweight wheelchair	Y	28	112	$5,051

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Keith Iverson Harrop, M.D.?

Tedicare shows public-source Medicare data for Keith Iverson Harrop, M.D. (NPI 1093080418), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Keith Iverson Harrop, M.D. have ACO affiliation data?

Keith Iverson Harrop, M.D. is shown with ACO affiliation data for LTC ACO (MSSP, ACO ID A2973) and Sound Physicians Long Term Care Managment II (MSSP, ACO ID A5538).

What billing organization is linked to Keith Iverson Harrop, M.D.?

Keith Iverson Harrop, M.D. is linked to M MEDICAL GROUP, INC. (billing NPI 1780056168) in the available physician profile data.

Does Keith Iverson Harrop, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.